Human type antihuman IgE receptor antibody and fragment
US7384633B2 · kind B2 · utility
6Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2002 |
| Grant date | Jun 10, 2008 |
| Priority date | — |
| Expiry date | Sep 28, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/805
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antibody or an antibody fragment is provided that is efficacious for treating allergic diseases in which IgE is involved. A human antibody and a fragment thereof to a receptor (FcεRI) having high affinity to Fc portion of IgE was obtained using phage antibody display technique. The human anti-IgE receptor antibody and a fragment thereof of the invention has an activity to inhibit the binding between IgE and IgE receptor and hence is expected to be useful as a medicament for treating allergic diseases caused by the binding between IgE and IgE receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.